## AMGN: Amgen Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -4.4% below STRENGTH zone (3.0-6.0%); PEG 1.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($301.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Who Owns Amgen? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251209T130753 | Bullish | Relevance: 100%
-  This article details the top shareholders of Amgen Inc. (NASDAQ: AMGN), primarily large institutional investors and passive funds, alongside recent adjustments by active managers and hedge funds. It also reviews recent insider trading activity, noting that sales were modest and purchases by directors appeared administrative, suggesting a neutral stance on near-term performance. The overall sentiment indicates strong long-term confidence in Amgen's cash flow durability and pipeline potential.

**2. Amgen Announces Dividend for the First Quarter of 2026, Payable on March 6, 2026**
- Source: marketscreener.com | 20251209T215227 | Bullish | Relevance: 99%
-  Amgen has declared a dividend of $2.52 per share for the first quarter of 2026. This dividend is scheduled to be paid on March 6, 2026, to all stockholders recorded as of February 13, 2026. This announcement follows a recent 5.9% increase in Amgen's dividend.

**3. Amgen Raises Quarterly Dividend to $2.52 a Share From $2.38, Payable March 6 to Shareholders of Record as of Feb. 13**
- Source: marketscreener.com | 20251209T210752 | Bullish | Relevance: 99%
- Amgen Inc. has announced an increase in its quarterly dividend to $2.52 per share, up from $2.38 per share. This dividend is scheduled to be paid on March 6, 2026, to shareholders of record as of February 13, 2026. The increase signifies an approximate 5.9% boost in the company's dividend per share.

**4. Amgen Inc. $AMGN Shares Purchased by Daiwa Securities Group Inc.**
- Source: MarketBeat | 20251209T103052 | Somewhat-Bullish | Relevance: 99%
-  Daiwa Securities Group Inc. has increased its holdings in Amgen Inc. by 5.1% in the second quarter, bringing its total ownership to 229,666 shares valued at $64.125 million. Several other hedge funds also adjusted their stakes in Amgen, while some corporate insiders sold shares. Wall Street analysts have issued mixed ratings for Amgen, with a consensus "Moderate Buy" and an average target price of $335.65.

**5. Jump Financial LLC Acquires 21,920 Shares of Amgen Inc. $AMGN**
- Source: MarketBeat | 20251210T120752 | Somewhat-Bullish | Relevance: 99%
-  Jump Financial LLC significantly increased its stake in Amgen Inc. by 1,449.7%, acquiring an additional 21,920 shares, bringing its total holdings to 23,432 shares valued at $6.542 million. This comes as Amgen reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. The company currently holds a "Moderate Buy" rating from analysts with an average price target of $335.65.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Wells Fargo | $325 | $300 | +8% |
| 2025-12-03 | BMO Capital | $372 | $335 | +11% |
| 2025-11-14 | Piper Sandler | $381 | $342 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Wells Fargo | main | Equal-Weight |
| 2025-12-03 | BMO Capital | main | Outperform |
| 2025-11-14 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 7 ($2.74M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.3%)
- Blackrock Inc.: 8.6% (-1.2%)
- State Street Corpora: 5.4% (-0.2%)
- Capital Internationa: 3.6% (+1.5%)
- Capital World Invest: 3.5% (+11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Forward P/E 14.5x stretched relative to 3% growth. Quality metrics strong (ROE 82%, margin 20%). Balance sheet: $4.2B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($2.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $170.9B |
| Beta | 0.45 |
| 52W Range | $253.30 - $346.38 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 14.5 |
| Current P/E | 14.9 |
| YoY Growth | 3.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -4.4% (minimal 5-day change). Below STRENGTH zone by 7.4pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-4.59), momentum weakening. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.37% (CS: 5) | Weak |
| RSI_14 | 42.9 | Neutral |
| MACD Histogram | -4.59 | Bearish |
| vs SMA20 | 0.948x | Below |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.069x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $317.38
- **Stop Loss:** $301.74 (4.9% risk)
- **Target:** $333.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $27,929.44
- **Portfolio %:** 27.93%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $4.74)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.01 | $5.64 | +12.5% |
| 2025Q2 | $5.28 | $6.02 | +14.1% |
| 2025Q1 | $4.26 | $4.90 | +15.0% |
| 2024Q4 | $5.08 | $5.31 | +4.6% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*